{"cik":1990550,"taxonomy":"us-gaap","tag":"DeferredIncomeTaxLiabilitiesNet","label":"Deferred Income Tax Liabilities, Net","description":"Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.","entityName":"Ambrx Biopharma, Inc.","units":{"USD":[{"end":"2022-12-31","val":880000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2022Q4I"},{"end":"2023-09-30","val":880000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2023Q3I"}]}}